Histamine in cancer immunotherapy: a preclinical background.

Histamine in cancer immunotherapy: a preclinical background.

Item
http://www.wikidata.org/entity/Q34689415
Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysisSpotlight on histamine dihydrochloride in acute myeloid leukaemia.Individual patient data meta-analysis of randomized trials evaluating IL-2 monotherapy as remission maintenance therapy in acute myeloid leukemia.Biogenic amines and polyamines: similar biochemistry for different physiological missions and biomedical applications.T lymphocytes as a target of histamine actionMonocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma--results from a randomised phase II trialTwo randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma.In vivo assessment of the antiproliferative properties of interferon-alpha during immunotherapy: Ki-67 (MIB-1) in patients with metastatic renal cell carcinoma.Effect of continuous high intensity focused ultrasound in a squamous cell carcinoma tumor model compared to muscle tissue evaluated by MRI, histology, and gene expression.Histamine regulates growth of malignant melanoma implants via H2 receptors in mice.Association of asthma with the risk of acute leukemia and non-Hodgkin lymphoma.Improved efficacy of a novel anti-angiogenic drug combination (TL-118) against colorectal-cancer liver metastases; MRI monitoring in mice.Histamine dihydrochloride and cancer.Histamine H2 Receptor in Blood Cells: A Suitable Target for the Treatment of Acute Myeloid Leukemia.
P2860

Histamine in cancer immunotherapy: a preclinical background.

Item
http://www.wikidata.org/entity/Q34689415
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Histamine in cancer immunotherapy: a preclinical background.
@ast
Histamine in cancer immunotherapy: a preclinical background.
@en
Histamine in cancer immunotherapy: a preclinical background.
@nl
type
label
Histamine in cancer immunotherapy: a preclinical background.
@ast
Histamine in cancer immunotherapy: a preclinical background.
@en
Histamine in cancer immunotherapy: a preclinical background.
@nl
prefLabel
Histamine in cancer immunotherapy: a preclinical background.
@ast
Histamine in cancer immunotherapy: a preclinical background.
@en
Histamine in cancer immunotherapy: a preclinical background.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Histamine in cancer immunotherapy: a preclinical background
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921